Ardelyx Inc gears up for high-potential growth but faces formidable execution risks in complex diseases.
Overview
Ardelyx Inc. is a biopharmaceutical firm focused on developing medicines for gastrointestinal and cardiorenal diseases. Its major product, tenapanor, is commercialized under two brands: IBSRELA for IBS-C and XPHOZAH for hyperphosphatemia. These represent the company's first market launches, while strategic partnerships extend its global reach.